Innovation Kyoto 2016 Investment Limited Partnership ("KYOTO-iCAP No.1 Fund"), with Kyoto University Innovation Capital Corporation ("Kyoto iCAP") (Head office: Sakyo-ku, Kyoto; Representative Director: Koji Murota) as unlimited liability partner, has made an investment in AFI Technology Inc. ("AFI") (Head office: Sakyo-ku, Kyoto; Representative Director: Takaharu Enjoji), a venture company that utilizes research results from Kyoto University.

Execution of Investment in ○AFI
AFI is a company that develops and markets equipment and devices for rapid, label-free separation and purification of cells and microorganisms based on fundamental technologies developed in collaboration with the Department of Breast Surgery, Graduate School of Medicine, Kyoto University (Professor Masakazu Toi),It is recognized as a one-of-a-kind technology that satisfies unmet needs in a wide range of fields, including quality inspection, clinical testing, and bio-product manufacturing.

Now, Kyoto iCAP is following up on AFI's Series A private placement in May 2016 with a Series B private placement totaling 430 million yen,(Head office: Chuo-ku, Tokyo; President: Sachiko Hirabayashi), SMBC Venture Capital (Head office: Chuo-ku, Tokyo; President: Tatsufumi Ishibashi), Chushin Venture Capital Co. (Head office: Chuo-ku, Tokyo; President: Satoshi Morikawa)In response to the request, the Company invested ¥200 million in the company as a lead investor.

AFI is the result of this financing,Eresta" food microbiology analyzer, "Eresta Core" clinical microbiology concentrator, "Eresta Sort" cell separator, andProducts for various fields as the Eresta SeriesThe company will launch the product in the market in earnest and begin overseas development.

Kyoto iCAP, through its September 2017 capital alliance with SCREEN Holdings Corporation (Head Office: Kamigyo-ku, Kyoto; President: Eiji Kakiuchi) and Kyokuto Pharmaceutical Industries, Ltd. (Head Office: Chuo-ku, Tokyo; President: Hiroshi Kikuchi), and now with Yamato Scientific Corporation, and others, AFI is We expect AFI to form a large network with partner companies through the capital alliance with Yamato Scientific Co.

Overview of AFI Technology, Inc.

Establishment	May 2013
Business	Development of separation and purification equipment for cells and microorganisms using electrical measurement and microfluidic technology
Head Office Location	Sakyo-ku, Kyoto
President & CEO	Ryuji Enjoji